Clinical Advantages Over Rituximab

Hanny argues yonalimab shows better short-term outcomes, fatigue improvement, and quality-of-life benefits versus rituximab studies.

Play episode from 06:35

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!